Submitted by Anonymous (not verified) on 25 March 2024 - 10:12
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised
Source: